Novartis Asserts In India Court Incremental Change Same As Inventive
This article was originally published in PharmAsia News
Executive Summary
During an Indian high-court hearing, a Novartis attorney argued that any incremental change in a drug's efficacy should qualify as an innovative step, qualifying it for patent protection.